Related Experiment Video
Updated: Aug 14, 2026

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
Cystatin C: unsuited to use as a marker of kidney function in the intensive care unit
Insights
Cystatin C is not a reliable marker for glomerular filtration rate in critically ill patients. Its accuracy is compromised by factors like body mass, thyroid disorders, and the chosen threshold for renal dysfunction.
Area of Science:
- Nephrology
- Critical Care Medicine
- Clinical Chemistry
Background:
- The utility of cystatin C as a glomerular filtration rate (GFR) marker in critically ill patients is debated.
- Previous studies have suggested cystatin C as a superior alternative to creatinine for GFR estimation.
Discussion:
- The 'gold standard' for GFR measurement in the original study (body surface corrected creatinine clearance) is unreliable in obese/lean patients common in intensive care.
- The study's renal dysfunction cutoff (80 ml/min) deviates from the accepted standard (50 ml/min), potentially skewing results.
- Exclusion of patients with thyroid disorders is problematic, as critical illness often mimics thyroid dysfunction and impacts cystatin C accuracy.
Key Insights:
- Cystatin C levels are inversely affected by thyroid dysfunction (low in hypothyroidism, high in hyperthyroidism), rendering it unsuitable for GFR assessment in these cases.
- Creatinine clearance, used as a comparator, has limitations in extreme body compositions (obesity, leanness).
- Discrepancies in GFR assessment thresholds and patient selection criteria raise concerns about cystatin C's applicability in intensive care settings.
Outlook:
- Further validation of GFR markers in critically ill populations with diverse physiological states is warranted.
- Standardization of GFR assessment methodologies, including the choice of 'gold standard' and diagnostic cutoffs, is crucial for reliable clinical interpretation.
- Investigating alternative or adjusted biomarkers that account for critical illness-related physiological changes may be necessary.
Abstract:
: We read with interest the article by Villa and coworkers 1 advocating the use of cystatin C as a measure of glomerular filtration rate (GFR) in critically ill patients. However, we should like to draw attention to several flaws in this study. First, Villa and coworkers compared cystatin C with creatinine as a measure of GFR, using body surface corrected creatinine clearance as, what they call, a 'gold standard'. However, in the Discussion section of that report inulin and iothalamate clearances are mentioned as gold standards, but they were not used by these investigators. The use of body surface area corrected creatinine clearance is questionable in both obese and excessively lean individuals because the correlation between surface area and lean body mass may be lost. Both types of patients are frequently encountered in intensive care. Second, Villa and coworkers employ a cutoff of 80 ml/min to identify renal dysfunction, whereas a value of 50 ml/min is generally accepted 2. This could have a major influence on the presented results. Third, patients with thyroid disorders or on corticosteroid therapy were excluded. Almost all patients with critical illness have low tri-iodothyronine values because of changes in thyroid hormone metabolism ('nonthyroidal illness'), thus making recognition of thyroid disorders problematic. Finally, we showed 3 that, in patients with thyroid dysfunction, cystatin C is not a suitable measure of GFR. In hypothyroidism creatinine levels are elevated but cystatin C levels are low, whereas in hyperthyroidism creatinine levels are low and cystatin C levels elevated. Taken together, we disagree with the authors that cystatin C could be used as a marker of GFR in intensive care patients.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Serum Studies: Renal Function Tests
Urine Studies II: Urine Culture and Sensitivity Test
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care